Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C

NCT00088504

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Joseph L. Cochran, M.D. Birmingham, Alabama, United States

Suresh Karne, M.D., Ph.D. Huntsville, Alabama, United States

Vijayan Balan, M.D. Phoenix, Arizona, United States

Michael P. DeMicco, M.D. Anaheim, California, United States

View all 67 locations

View Trial Details

Completed

VX-950 and Peginterferon for Hepatitis C

NCT00251199

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Call for information Homburg/Saar, Germany

Call for information Amsterdam, Netherlands

View Trial Details

Completed

Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C

NCT00262483

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Call for information San Antonio, Texas, United States

Call for information Santurce, Puerto Rico

View Trial Details

Completed

Health Behavior Feedback Study for Veterans With Hepatitis C

NCT00229580

Conditions: Alcohol Abuse, Alcohol-Related Disorders, Alcoholism, +15 more
Locations: VA Puget Sound Health Care System Seattle, Washington, United States

View Trial Details

Completed

Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C

NCT00298714

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

NCT00196586

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +24 more
Locations: Hopital Européen Georges Pompidou Paris, France

View Trial Details

Completed

Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis

NCT00043303

Conditions: Blood-Borne Infections, Cirrhosis, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Treatment Insulin Resistence in HCV G-1 Patient

NCT00546442

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +20 more
Locations: Hospital Germans Trias i Pujol Badalona, Barcelona, Spain

Hospital del Mar Barcelona, Spain

Hospital Parc Taulí Sabadell, Barcelona, Spain

Hospital General de Ciudad Real Ciudad Real, Spain

View all 19 locations

View Trial Details

Completed

Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C

NCT00148863

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Hopital Haut Leveque Service d'Hepato-Gastro-Enterologie Pessac, France

Hôpital du Haut-Levêque Pessac, France

View Trial Details

Completed

Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

NCT00097045

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Moscow, Russia

Saint Petersburg, Russia

Smolensk, Russia

View Trial Details

Flaviviridae Infections

Flaviviridae Infections trial results

Related conditions